General Information of the Compound
Compound ID
CP0849176
Compound Name
3-(3-o-tolyl-1,2,4-oxadiazol-5-yl)benzoic acid
    Show/Hide
Structure
Formula
C16H12N2O3
Molecular Weight
280.283
Canonical SMILES
Cc1ccccc1-c1noc(-c2cccc(C(=O)O)c2)n1
    Show/Hide
InChI
InChI=1S/C16H12N2O3/c1-10-5-2-3-8-13(10)14-17-15(21-18-14)11-6-4-7-12(9-11)16(19)20/h2-9H,1H3,(H,19,20)
    Show/Hide
InChIKey
WHNBOVWEWUVNOZ-UHFFFAOYSA-N
Physicochemical Property
logP
3.41022
Rotatable Bonds
3
Heavy Atom Count
21
Polar Areas
76.22
Hydrogen Bond Donor Count
1
Hydrogen Bond Acceptor Count
4
Complexity
21

"RO5" indicates the cutoff set by lipinski's rule of five:

(1) Molecular weight less than 500 Dalton;

(2) xlogp less than 5;

(3) No more than 5 hbonddonor (Hydrogen Bond Donor Count);

(4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count);

(5) No more than 10 rotbonds (Rotatable Bond Count).

    Show/Hide
Click to Show/Hide the External Link(s) of This Compound
PubChem ID
CID: 62925495
ChEMBL ID
CHEMBL3589975
Map of Molecular Bioactivity Related to the Compound
Map of Molecular Bioactivity Related to the Compound

Compound
Cell Line
Protein

Bioactivity Value:

<= 0.1 μM
> 0.1 μM and <= 10 μM
> 10 μM
Imprecise Activity
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT01286, Bile acid receptor
Cell-based Assay
Cell Line ID Cell Line Name Cell Line Organism
CL000017 HeLa Homo sapiens (Human)  1
1
EC50 = 7.2 nM
   TI
   LI
   LO
   TS